News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
EUROAPI and Priothera Enter CDMO Agreement for an Oncology Project
Wednesday, June 19, 2024EUROAPI has secured a fiveyear agreement with Priothera a biotechnology company that specializes in treatments for blood cancers and enhancements in CART cell therapies Priothera operates out of Dublin Ireland with an additional branch in SaintLouis...
RevOpsis and Kemwell Biopharma Establish Partnership to Accelerate the Development of Innovative Multispecific Biologics
Tuesday, June 18, 2024RevOpsis Therapeutics a pioneering biopharmaceutical company focused on multispecific ophthalmic therapies and Kemwell Biopharma a toptier contract development and manufacturing organization
Charles River and Captain T Cell Collaborate on Plasmid DNA and Viral Vector Manufacturing for Gene-Modified Cell Therapy
Tuesday, June 18, 2024Charles River Laboratories International Inc has entered into an agreement with Captain T Cell a spinoff from the prestigious Max Delbrck Center in Berlin Germany to collaborate on a plasmid DNA
Acquisition of Argatroban Business in Europe
Monday, June 17, 2024Ethypharm has entered into an agreement with Mitsubishi Tanabe Pharma Corporation MTPC to acquire the selective antithrombin agent Argatroban monohydrate marketed under various brands including Argatra Arganova Novastan Exembol for distribution in Eu...
XEOMIN® (IncobotulinumtoxinA) Receives Approval for New Therapeutic Use in Switzerland
Saturday, June 15, 2024Merz Therapeutics a division of the Merz Group specializing in neurotoxins has recently obtained approval from Swissmedic the Swiss Agency for Therapeutic Products for XEOMIN
Biosplice and Novo Nordisk Collaborate on Diabetes Solutions
Friday, June 14, 2024Biosplice Therapeutics Inc a leader in biotechnology specializes in creating innovative treatments through the use of smallmolecule inhibition targeting DYRKCLK kinases Recently Biosplice has formed a strategic alliance with Novo Nordisk to develop n...
NIIMBL and OAGi Partner to Create Open-Source Ontologies for Biopharmaceutical Manufacturing
Friday, June 14, 2024The National Institute for Innovation in Manufacturing Biopharmaceuticals has transitioned biopharmaceutical manufacturing ontologies to The Open Applications Group facilitating
Foundation Medicine and Repare Therapeutics Collaborate to Provide Genomic Profiling Services for Clinical Trials and Develop a Companion Diagnostic for Lunresertib
Thursday, June 13, 2024Foundation Medicine Inc has announced a partnership with Repare Therapeutics a leader in precision
Helsinn Group and Chugai Pharma Europe Renew Their Collaboration to Distribute AKYNZEO® in the UK and Ireland
Thursday, June 13, 2024Helsinn Group a global pharmaceutical company with over years of experience in supportive care oncology and dermatooncology along with Chugai Pharma Europe Ltd the European subsidiary
Essential Pharma Partners with AGC Biologics for Immunotherapy Production in High-Risk Neuroblastoma Treatment
Wednesday, June 12, 2024Essential Pharma a global specialty pharmaceutical company has formed a strategic alliance with AGC Biologics a leading contract development and manufacturing organization in the biopharmaceutical
